Associate
Victoria Randall is a chartered UK patent attorney and a European patent attorney. With a background in biomedical sciences, she works with a diverse portfolio of clients, including global pharmaceuticals and startup biotechnology companies. Victoria is the recipient of the "IP Rising Star" Award 2023 from Women in Business Law EMEA.
Victoria entered the patent profession in 2009 and joins Finnegan having previously worked for two large UK firms and a boutique firm. She has acquired extensive experience in a broad range of life sciences subject matter. Her areas of interest include personal medicine, antibody technologies, antisense therapeutics, blood products, vaccines, gene manipulation, and stem cell culture methods.
Victoria enjoys all aspects of prosecution, including drafting, filing, examination, and grant procedures. She has experience with oppositions and appeals, representing both patentee and opponent at Oral Proceedings before the European Patent Office (EPO). She has managed large, complex portfolios protecting high-value pharmaceuticals. Victoria has experience prosecuting supplementary protection certificates and has been involved in litigation proceedings before the UK High Court.
Victoria has a first class degree in Biomedical Sciences from The University of Sheffield and a Ph.D. from University College London. She conducted research at the Institute of Child Health at Great Ormond Street Hospital, where she focused on the genetic interactions underlying two congenital syndromes.
Event
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Event
Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed
December 12, 2023
Webinar
European IP Blog
The EPO’s “10 Day Notification Period” Comes to an End The EPO’s “10 Day Notification Period” Comes to an End
11 October 2023
European IP Blog
The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO
March 24, 2023
Event
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Announcement
Finnegan’s Victoria Randall Receives Women in Business Law “IP Rising Star” Award Finnegan’s Victoria Randall Receives Women in Business Law “IP Rising Star” Award
June 29, 2023
Women in Business LawAward/Ranking
Finnegan Shortlisted for “German Firm of the Year” by Women in Business Law Awards EMEA Finnegan Shortlisted for “German Firm of the Year” by Women in Business Law Awards EMEA
May 9, 2023
Women in Business LawDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.